Once-Daily Tiotropium Respimat® Add-On Therapy Has a Safety Profile Comparable With Placebo in Children and Adolescents

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2016.12.308
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tiotropium in Children and Adolescents With Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2020English

A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Thorax
PulmonaryRespiratory Medicine
2015English

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2009English

Tiotropium Provides Greater Improvements in FEV1 Than an LTRA as Add-On to ICS in Children and Adolescents With Asthma: A Systematic Review

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

New Abilities of Administration of Tiotropium Bromide Using the Aerosol Delivery Device Respimat®

Pulmonologiya
PulmonaryRespiratory Medicine
2013English

Efficacy and Safety of Olodaterol Once Daily Delivered via Respimat® In Patients With GOLD 2–4 COPD: Results From Two Replicate 48-Week Studies

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2014English

Effect of Once-Daily Tiotropium and Olodaterol, Alone and Combined With Exercise Training, on Two Measures of Walking Capacity in Patients With COPD

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Respiratory Medicine
PulmonaryRespiratory Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy